91 results
8-K
EX-99.1
VRDN
Viridian Therapeutics Inc
8 May 24
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
7:09am
of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.
Viridian is advancing multiple
8-K
EX-99.1
8z01ek7a1
27 Feb 24
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
EX-99.1
bp42gzdx2h 7beq687k
8 Jan 24
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
8:08am
8-K
EX-99.1
7ik qjbs3
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:15am
8-K
EX-99.1
4y41cyys uv
13 Nov 23
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
8-K
EX-99.1
1j03 vepop6rgecbvpj
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
51u3rt8kxfl bej
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
ao1qpg4d6d2sn
10 Jul 23
Regulation FD Disclosure
5:13pm
8-K
EX-10.1
kmjqp6cnndyjnueo
16 Jun 23
Departure of Directors or Certain Officers
4:31pm